Portfolio A to Z
Advent invests in two principal areas: Life Sciences and Technology. Its portfolio companies are in a variety of geographies, in a range of sectors and at differing stages of growth.
| Next Page 1 2 3 | |||
| Next Page 1 2 3 | |||
| 4-Antibody | Novel technology for developing new antibodies Advent Contact: Raj Parekh |
 |
|
| Adeptra | Interactive alert services Advent Contact: Martin McNair |
 |
|
| Algeta | Novel anticancer agents based on alpha emitters
Oslo Bors IPO March 2007 (ALGETA) Advent Contact: Shahzad Malik |
 |
|
| AmberFin | Processing of digital media content Advent Contact: Peter Baines |
 |
|
| AMT | Gene therapy for orphan indications
Euronext IPO June 2007 (AMT)
Advent Contact: Raj Parekh |
 |
|
| ASK | Contactless smartcard design & manufacture Advent Contact: Peter Baines |
 |
|
| Audium Semiconductor | Ultra energy-efficient audio semiconductors Advent Contact: Martin McNair |
 |
|
| Avila | Development of novel small molecule drugs focused on cancer, autoimmune diseases and viral infection. Advent Contact: Raj Parekh |
 |
|
| BridgeCo | Semi-conductors for networked consumer electronics Advent Contact: Martin McNair |
 |
|
| Cardiac Assist | Extracorporeal ventricular assist device Advent Contact: Shahzad Malik |
 |
|
| CardioKine | Cardio-renal drug development Advent Contact: Shahzad Malik |
 |
|
| Cellnovo | Development of next-generation small disposable insulin pumps Advent Contact: Raj Parekh |
 |
|
| Conatus Pharmaceuticals | New therapeutic agents for treatment of liver disease. Advent Contact: Shahzad Malik |
 |
|
| Dailymotion | Video sharing site Advent Contact: Peter Baines |
 |
|
| Echovox | Mobile media solutions provider Advent Contact: Frédéric Court |
 |
|